|
|
Volumn 5, Issue 3, 2012, Pages 175-177
|
|
Radionuclide generators - A new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTINIUM 225;
BISMUTH 213;
DRUG CARRIER;
GALLIUM 68;
GERMANIUM;
IBRITUMOMAB TIUXETAN;
MOLYBDENUM 99;
RADIOPHARMACEUTICAL AGENT;
RADIUM CHLORIDE RA 223;
RHENIUM 188;
RUBIDIUM 82;
RUBIDIUM CHLORIDE RB 82;
SCANDIUM;
STRONTIUM 82;
STRONTIUM 90;
TECHNETIUM 99M;
TRACER;
YTTRIUM 90;
ANTIBODY LABELING;
BONE METASTASIS;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CLINICAL PRACTICE;
CLINICAL TRIAL (TOPIC);
COMMERCIAL PHENOMENA;
CYCLOTRON;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG MANUFACTURE;
DRUG TARGETING;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TUMOR;
GOOD MANUFACTURING PRACTICE;
GOVERNMENT;
HOSPITAL PHARMACY;
HUMAN;
ISOTOPE LABELING;
LINEAR ENERGY TRANSFER;
NEUROENDOCRINE TUMOR;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIOACTIVITY;
RADIOCHEMISTRY;
RADIODIAGNOSIS;
RADIOISOTOPE THERAPY;
REIMBURSEMENT;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
UNIVERSITY HOSPITAL;
|
|
EID: 84863546542
PISSN: 18744710
EISSN: 18744729
Source Type: Journal
DOI: 10.2174/1874471011205030175 Document Type: Editorial |
|
Times cited : (14)
|
|
References (0)
|
